Noteboom The Law Firm

Experimental Drug May Help Treat Bone Marrow Disorder

An experimental oral drug, INCB018424, may help treat individuals with bone marrow disorder. Bone marrow disorder, known as myelofibrosis, is a deadly condition that can cause a person to be unable to work and in need of Social Security disability benefits.

There are currently no approved therapies to help treat Myelofibrosis, so the positive early signs of this new experimental drug are proving hopeful. It has been found to reduce enlarged spleens, along with improving other symptoms patients experience such as fatigue and pain.

There are approximately 3,000 new cases of this aggressive bone marrow disorder diagnosed every year in the United States. The average life expectancy for those with myelofibrosis is just 5 to 7 years. With no cure or effective treatment to curtail the symptoms associated with myelofibrosis, patients are oftentimes left to suffer.

So far, the results of this experimental drug have shown that in just 1 month of treatment, about half of the patients being tested experienced a 50% decrease in common symptoms with almost 60% of the patients continuing to have a decrease in symptoms 6 months later.

It was also shown to reduce enlarged spleens by 35% or more in almost half of the patients. In addition there was an improvement in weight gain and strength for many of them.

This is just one step in ongoing research that will continue to help individuals who have myelofibrosis.

If you suffer from a serious, life-threatening condition that prevents you from working you may qualify for Social Security disability benefits. Contact a Social Security disability attorney who can advise you of eligibility.

Get a FREE Social Security disability guide and avoid the common mistakes many claimants make during their application or appeal. If you or your loved is suffering from a severe physical or mental disability, contact The Law Offices of LaVan & Neidenberg, P.A. 1-888-234-5758